Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025
Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025 Virtual webinar to feature expert insights on unmet need, treatment landscape and potential clinical utility of Aryl Hydrocarbon Receptor (AhR) modulation in ulcerative colitis GlobeNewswire October 22, 2025 LA JOLLA, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology […]